Safety and immunogenicity of Q fever vaccine in children aged 10 to 15 years.

计划入组 20 人

Q Fever and Auto-immunity

计划入组 300 人 · 首次发布于 2016 年 7 月 4 日

Safety and Immunogenicity of Q Fever Vaccine

首次发布于 2014 年 3 月 20 日

Q fever vaccine

T-cell epitope-based vaccine (Q Fever)

Q-8045

Q-Med AB

Sweden

Q Therapeutics, Inc.

United States

Q BioMed Inc.

mNGS Identifies Acute Q Fever Presenting as Sepsis with Multisystem Involvement in an Immunosuppressed Patient

CSL Seqirus Opens $1 Billion Cell-Based Vaccine Manufacturing Facility in Melbourne

Fever Prevention Post-Stroke Reduces Fever Burden, But Fails to Improve Functional Outcomes